Clearside Financial Statements From 2010 to 2025

Clearside Biomedical Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 34.1 M 25.1 M 27.5 M Slightly volatile Other Current Liabilities 2.4 M 1.6 M 2 M Slightly volatile Total Current Liabilities 6.9 M 4.8 M 5.6 M Slightly volatile Property Plant And Equipment Net 4 M 3.8 M 1.2 M Slightly volatile Cash 21.2 M 20 M 17.1 M Slightly volatile Non Current Assets Total 4 M 3.9 M 1.4 M Slightly volatile Other Assets 0.86 0.9 532.2 K Slightly volatile Cash And Short Term Investments 30.5 M 20 M 24.6 M Slightly volatile Common Stock Shares Outstanding 44 M 73.8 M 45.8 M Very volatile Non Current Liabilities Total 62.1 M 59.2 M 20.1 M Slightly volatile Other Current Assets 1 M 747 K 842.8 K Slightly volatile Total Liabilities 67.2 M 64 M 25.5 M Slightly volatile Total Current Assets 32.2 M 21.3 M 25.9 M Slightly volatile Common Stock 80.8 K 77 K 33.5 K Slightly volatile Short and Long Term Debt Total 667.9 K 703 K 6 M Slightly volatile Accounts Payable 1.8 M 1.5 M 1.8 M Pretty Stable Common Stock Total Equity 73.7 K 70.2 K 32.7 K Slightly volatile Liabilities And Stockholders Equity 36.9 M 25.1 M 27.9 M Slightly volatile Property Plant And Equipment Gross 5.2 M 5 M 1.5 M Slightly volatile Other Liabilities 41 M 39.1 M 12.6 M Slightly volatile Long Term Debt 6.3 M 4.4 M 4.8 M Very volatile Deferred Long Term Liabilities 588 K 544.5 K 927 K Slightly volatile Short and Long Term Debt 847.3 K 891.9 K 1.8 M Slightly volatile Short Term Debt 1.2 M 750 K 1.5 M Slightly volatile Property Plant Equipment 643.4 K 868.2 K 521.9 K Slightly volatile Long Term Debt Total 6.6 M 4.4 M 4.8 M Very volatile Capital Surpluse 222.9 M 343.8 M 156.3 M Slightly volatile Current Deferred Revenue 64.1 K 67.5 K 1.1 M Pretty Stable Net Working Capital 27.7 M 16.5 M 25.6 M Very volatile Capital Stock 61.1 K 77 K 44.1 K Slightly volatile Capital Lease Obligations 789.6 K 703 K 1.1 M Slightly volatile Non Current Liabilities Other 54.8 M 52.2 M 12.1 M Slightly volatile
Clearside Biomedical Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 131.8 K 226 K 106.5 K Slightly volatile Selling General Administrative 10 M 11.8 M 8.2 M Slightly volatile Other Operating Expenses 33 M 30.5 M 26.9 M Slightly volatile Research Development 22.8 M 18.6 M 18.6 M Slightly volatile Total Operating Expenses 32.9 M 30.4 M 26.8 M Slightly volatile Selling And Marketing Expenses 145.6 K 163.8 K 178.6 K Slightly volatile Interest Income 1.1 M 1.5 M 684 K Slightly volatile Reconciled Depreciation 137.8 K 226 K 174.4 K Slightly volatile
Clearside Biomedical Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 3.2 M 4.5 M 2.6 M Slightly volatile Begin Period Cash Flow 19.7 M 28.9 M 15.8 M Slightly volatile Depreciation 131.8 K 226 K 106.5 K Slightly volatile Capital Expenditures 1 M 977 K 322.2 K Slightly volatile Total Cash From Financing Activities 19.4 M 16.4 M 21.5 M Very volatile End Period Cash Flow 21.4 M 20 M 17.2 M Slightly volatile Change To Netincome 3.6 M 5.7 M 2.8 M Slightly volatile Issuance Of Capital Stock 16.8 M 16.4 M 50 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 40.03 42.1353 213 Slightly volatile Days Sales Outstanding 88.79 111 106 Slightly volatile Stock Based Compensation To Revenue 2.58 2.7121 12.4482 Very volatile Capex To Depreciation 3.49 4.323 4.6094 Very volatile EV To Sales 29.0 30.5266 189 Pretty Stable Inventory Turnover 0.15 0.17 0.1891 Slightly volatile Days Of Inventory On Hand 1.5 K 1.7 K 1.9 K Slightly volatile Payables Turnover 0.1 0.1026 0.1142 Slightly volatile Sales General And Administrative To Revenue 6.74 7.0956 39.7211 Very volatile Research And Ddevelopement To Revenue 10.61 11.1719 171 Very volatile Capex To Revenue 0.66 0.5871 0.3571 Pretty Stable Cash Per Share 0.26 0.2713 1.0067 Very volatile Days Payables Outstanding 5.7 K 3.6 K 7.7 K Slightly volatile Current Ratio 3.98 4.4376 4.5041 Pretty Stable Receivables Turnover 3.12 3.2821 8.6668 Slightly volatile Capex Per Share 0.011 0.0132 0.0085 Pretty Stable Revenue Per Share 0.0214 0.0225 0.0765 Pretty Stable Interest Debt Per Share 0.13 0.142 0.2494 Very volatile Debt To Assets 0.0266 0.028 0.2052 Pretty Stable Graham Number 0.25 0.28 0.3013 Slightly volatile Operating Cycle 106 111 1.5 K Slightly volatile Days Of Payables Outstanding 5.7 K 3.6 K 7.7 K Slightly volatile Quick Ratio 3.98 4.4376 4.4917 Pretty Stable Net Income Per E B T 0.81 0.93 0.9852 Slightly volatile Cash Ratio 2.88 4.1761 3.3032 Slightly volatile Days Of Inventory Outstanding 1.5 K 1.7 K 1.9 K Slightly volatile Days Of Sales Outstanding 88.79 111 106 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.82 1.0396 1.0055 Pretty Stable Fixed Asset Turnover 0.41 0.4354 6.3584 Very volatile Debt Ratio 0.0266 0.028 0.2052 Pretty Stable Price Sales Ratio 40.03 42.1353 213 Slightly volatile Asset Turnover 0.0629 0.0662 0.1017 Slightly volatile Gross Profit Margin 1.02 0.9105 0.9788 Slightly volatile
Clearside Biomedical Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 66.6 M 70.1 M 185.9 M Slightly volatile Enterprise Value 48.3 M 50.8 M 183.8 M Slightly volatile

Clearside Fundamental Market Drivers

Clearside Upcoming Events

About Clearside Biomedical Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports:

How To Invest In Clearside Details

Is Clearside Stock a good investment? Details

What is Clearside Biomedical's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details